Ireland
--:--IST
Recruiting Not applicable

Baduanjin Training for Depression and Anxiety Patients

NCT05589337 · tracked via the Priya Life Science China tracker
Phase
Not applicable
Started
2021-07-01
Last updated
2026-04-29

Condition(s) studied

Depression SymptomsAnxiety Symptoms

Investigational drug(s) / intervention(s)

BaduanjinHealth education

Baduanjin: The Baduanjin training program consisted of two 90-min training classes and at least five 30-min at-home practice sessions per week for 16-weeks. All sessions included 10 min of warmup and 10 min of cooldown.

Health education: Health education is provided by psychologist and TCM doctor, including work, rest, diet and other basic programs.

Study summary

In recent years, the number of people with symptoms of depression or anxiety are on the rise. The aims of the prospective randomized study are: (1) to examine the effects of Baduanjin breathing training on reducing symptoms of depression or anxiety, and (2) to explore the correlates between improvements of depression or anxiety symptom and changes of lung functions.

Eligibility

Sex
ALL
Min age
18 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria: * Subject with depression or anxiety symptom diagnosed by ICD-10. * Depression 7≤HAMD-17≤29,anxiety 7≤HAMA-14≤29. * Subject has a clear mind and the ability to read, to talk and to communicate. * Subject agrees to participate in this study and sign to the informed consent. Exclusion Criteria: * Subject with bipolar disorder, psychotic disorder, organic mental disorder and cognitive disorder. * Subject with alcohol abuse, substance dependence and suicidal behavior in past-year. * Subject has severe somatic disease. * Subject is pregnant or lactating women.

Primary outcome measure(s)

  • 17-item Hamilton Depression Rating Scale — Change from Baseline HAMD-17 at 16 weeks
    The HAMD-17 is a clinician-rated assessment (structured interview) of patients' depressive symptoms. Questions focus on depressive symptoms during the past 7 days, and higher cumulative scores indicate more severe depression.
  • 14-item Hamilton Anxiety Rating Scale — Change from Baseline HAMA-14 at 16 weeks
    The HAMA-14 is a clinician-rated assessment (structured interview) of patients' anxious symptoms. Questions focus on anxious symptoms during the past 7 days, and higher cumulative scores indicate more severe anxiety.

Trial sites (1)

FacilityCityRegionStatus
Shanghai Qigong Research Institute Shanghai Shanghai Municipality Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05589337 on ClinicalTrials.gov ↗ ← All trials in China